All In Biotech

Drug Trial Radar · NCT05642325

Vamikibart in Participants With Uveitic Macular Edema

A Phase III, Multicenter, Randomized, Double-Masked, Sham-Controlled Study to Investigate the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of Vamikibart Administered Intravitreally in Patients With Uveitic Macular Edema

Last checked: Nov 20, 2026Latest source record: Apr 17, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingPhase 3. Randomized with 256 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

256

Actual

Start

Mar 23, 2023

Primary completion

May 7, 2025

Study completion Dec 24, 2025

Sponsor

Lead sponsor
Hoffmann-La RocheRoche (Genentech) (RHHBY)
Sponsor type
Industry
First posted
Dec 8, 2022

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study will assess the efficacy and safety of vamikibart in participants with uveitic macular edema.

Conditions

  • Uveitic Macular Edema

Interventions

  • VamikibartDrug

    Participants will receive vamikibart IVT injection

  • ShamOther

    Participants will receive a sham procedure that mimics an IVT injection.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Proportion of participants with ≥ 15 letter improvement from baseline in best-corrected visual acuity (BCVA) at Week 16Time frame: Week 16

Locations

94 sites in 19 countries. Site status is shown where the registry gives one.

  • Associated Retina Consultants

    Phoenix, Arizona

  • Barnet Dulaney Perkins Eye Center

    Sun City, Arizona

  • Retina Consultants of Orange County

    Fullerton, California

  • Northern California Retina Vitreous Associates

    Mountain View, California

  • California Eye Specialists Medical group Inc.

    Pasadena, California

  • Retina Consultants of Southern California

    Redlands, California

  • Kaiser Permanente Riverside Medical Center

    Riverside, California

  • University of California, Davis, Eye Center

    Sacramento, California

  • Retinal Consultants Med Group

    Sacramento, California

  • Advanced Research

    Deerfield Beach, Florida

  • Retina Group of Florida

    Fort Lauderdale, Florida

  • University Retina and Macula Associates, PC

    Oak Forest, Illinois

  • Cumberland Valley Retina PC

    Hagerstown, Maryland

  • University of Michigan, Kellogg Eye Center

    Ann Arbor, Michigan

  • Duke Eye Center

    Durham, North Carolina

  • Cleveland Clinic

    Cleveland, Ohio

  • Erie Retina Research

    Erie, Pennsylvania

  • Mid Atlantic Retina

    Philadelphia, Pennsylvania

  • Retina Research Institute of Texas

    Abilene, Texas

  • Retina Consultants of Texas

    Bellaire, Texas

  • Retina Consultants of Texas

    Katy, Texas

  • Retina Group of Washington

    Fairfax, Virginia

  • University of Wisconsin

    Madison, Wisconsin

  • Centro Privado de Ojos

    Ciudad Autonoma Buenos Aires, Argentina

  • Buenos Aires Mácula

    Ciudad Autonoma Buenos Aires, Argentina

  • Consultorios Medicos Oftalmológicos

    Ciudad Autonoma Buenos Aires, Argentina

  • Oftalmologia Global

    Rosario, Argentina

  • Organizacion Medica de Investigacion

    San Nicolás, Argentina

  • Sydney Eye Hospital

    Sydney, New South Wales, Australia

  • Centre For Eye Research Australia

    East Melbourne, Victoria, Australia

  • Eye Surgery Associates

    Malvern, Victoria, Australia

  • Retina Specialists Victoria

    Rowville, Victoria, Australia

  • The Lions Eye Institute

    Nedlands, Western Australia, Australia

  • Peking Union Medical College Hospital

    Beijing, China

  • Beijing Tongren Hospital

    Beijing, China

  • The First Affiliated Hospital, Chongqing Medical University

    Chongqing, China

  • General Teaching Hospital Prague

    Prague, Czechia

  • CHU Nantes - Hotel Dieu

    Nantes, France

  • Hopital Lariboisiere

    Paris, France

  • Hôpital COCHIN

    Paris, France

Showing 40 of 94 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.